Price Alert

Vor Biopharma Inc. (VOR)

NASDAQ: VOR · Real-Time Price · USD

37.46

0.78 (2.13%)

At close: Oct 03, 2025, 3:59 PM

38.48

2.72%

After-hours: Oct 03, 2025, 07:40 PM EDT

2.13% (1D)

Bid	37.11
Market Cap	237.28M
Revenue (ttm)	3.69M
Net Income (ttm)	-1.66B
EPS (ttm)	-220.48
PE Ratio (ttm)	-0.17
Forward PE	-4.74
Analyst	Hold
Dividends	n/a

Ask	37.51
Volume	387,336
Avg. Volume (20D)	398,178
Open	36.88
Previous Close	36.68
Day's Range	36.88 - 39.43
52-Week Range	2.62 - 65.80
Beta	2.08
Ex-Dividend Date	n/a

About VOR

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol VOR

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for VOR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 month ago

+21.69%

Vor Bio shares are trading higher after the compan... Unlock content with Pro Subscription

1 month ago

+21.69%

Vor Biopharma shares are trading higher following the release of its Q2 reported financial results.

News

1 week ago · seekingalpha.com

Vor Biopharma: Transformed Company Is A High Risk Buy On Autoimmune Disease Promise

Vor Biopharma has rebounded from near-delisting by securing global rights (ex-China) to telitacicept, a promising autoimmune therapy. VOR's telitacicept targets multi-billion dollar autoimmune markets...

1 month ago · benzinga.com

Vor Bio Rallies On Strong Data For Autoimmune Drug Candidate

Vor Bio VOR stock is trading higher on Wednesday with a session volume of 10.83 million compared to the average volume of 17.99 million, as per data from Benzinga Pro.